🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

159,76 USD

Máx. histórico

185,50

98 días

Caída desde máximo

-13,88%

Rango 52 semanas

122,14 – 186,12

Variación hoy

-3,79%

Cierre anterior

166,05

Rango de hoy

159,53 – 167,68

Volumen hoy

1.482.485

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
23,70 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 17 horas
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/12/2020 95,60 95,78 93,81 94,00 -1,60% 2,06% 369.600
28/12/2020 98,16 98,31 95,31 95,53 -2,19% 3,06% 391.500
24/12/2020 98,46 99,24 96,46 97,67 -0,27% 2,82% 166.400
23/12/2020 98,76 98,88 96,34 97,93 -0,75% 2,57% 638.800
22/12/2020 99,88 101,26 98,33 98,67 -1,62% 2,93% 610.200
21/12/2020 99,74 101,76 98,56 100,29 -1,12% 3,21% 755.200
18/12/2020 100,91 102,33 100,09 101,43 +1,28% 2,22% 1.538.600
17/12/2020 99,00 100,75 97,76 100,15 +1,48% 3,02% 703.000
16/12/2020 95,30 99,28 94,39 98,69 +3,54% 5,13% 1.436.400
15/12/2020 93,59 95,48 92,40 95,32 +1,99% 3,29% 968.000
14/12/2020 90,78 94,55 90,78 93,46 +3,60% 4,15% 923.400
11/12/2020 92,24 92,24 89,81 90,21 -1,13% 2,63% 797.100
10/12/2020 91,33 92,48 89,77 91,24 -0,79% 2,97% 715.900
09/12/2020 91,63 92,09 89,66 91,97 +0,36% 2,65% 674.500
08/12/2020 91,00 92,13 90,05 91,64 +0,63% 2,29% 658.800
07/12/2020 95,37 96,46 90,46 91,07 -5,66% 6,29% 909.600
04/12/2020 98,34 99,40 96,52 96,53 -2,27% 2,93% 467.500
03/12/2020 96,91 100,00 96,91 98,77 +1,65% 3,19% 865.500
02/12/2020 95,24 97,41 94,46 97,17 +2,47% 3,10% 540.600
01/12/2020 94,88 95,46 93,73 94,83 -0,12% 1,82% 959.900
30/11/2020 96,16 97,91 93,94 94,94 -0,65% 4,13% 1.845.600
27/11/2020 94,79 95,56 93,95 95,56 +0,46% 1,70% 364.500
25/11/2020 95,58 96,94 93,45 95,12 -0,72% 3,65% 858.300
24/11/2020 94,09 97,34 93,38 95,81 +2,34% 4,21% 1.173.400
23/11/2020 89,30 95,11 89,30 93,62 +5,19% 6,51% 1.673.600
20/11/2020 87,70 90,22 87,56 89,00 +1,77% 3,03% 1.166.500
19/11/2020 87,29 88,01 86,02 87,45 +0,62% 2,28% 2.135.900
18/11/2020 91,92 92,17 86,67 86,91 -5,28% 5,98% 795.600
17/11/2020 92,70 93,50 90,99 91,75 -1,30% 2,71% 760.600
16/11/2020 92,44 95,39 92,03 92,96 +1,07% 3,63% 853.000